News & Events

The 11th annual Appel Alzheimer's Disease Research Institute Symposium brought together leading scientists and clinicians in the field to present the latest advances in understanding Alzheimer’s and related neurodegenerative diseases. The event was held at the Belfer Research Building on Nov. 9.

Helen and Robert Appel established the Institute in 2006 after they lost close friends to Alzheimer’s. “I am hopeful that we are closer than ever...

Dr. John Leonard, senior associate dean for innovation and initiatives, interim chair of the Weill Department of Medicine, and the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, was given the Lifetime Achievement Award from the Cancer Research and Treatment Fund. The organization funds research emphasizing the cause, prevention, treatment and cure of myeloproliferative neoplasms...

Researchers at Weill Cornell Medicine, Cornell Tech and Cornell's Ithaca campus have demonstrated the use of AI-selected natural images and AI-generated synthetic images as neuroscientific tools for probing the visual processing areas of the brain. The goal is to apply a data-driven approach to understand how vision is organized while potentially removing biases that may arise when looking at responses to a more limited set of researcher-selected images.

In the...

One of the hardest points on the translational road “from bench to bedside” can be the point where you have to turn over your discovery to a company you’ve founded—a company whose subsequent direction you won’t fully control.

“It’s sort of your baby that you’re turning over,” said Dr. Ronald Crystal, chair of the Department of Genetic Medicine and the Bruce Webster Professor of Internal Medicine at Weill Cornell Medicine, gene...

NEW YORK (Nov. 28, 2023)—Weill Cornell Medicine is dramatically expanding its campus and research footprint in New York City by securing five floors of 1334 York Ave., the current home of Sotheby's auction house, the institution announced today.

Located one block from Weill Cornell Medicine’s main campus on Manhattan’s Upper East Side, the site will add approximately 200,000 square feet of dedicated research space—an average of 40,000 square feet per floor—making it...

Dr. Bishoy M. Faltas, director of bladder cancer research at the Englander Institute for Precision Medicine at Weill Cornell Medicine, the Gellert Family-John P. Leonard, M.D. Research Scholar and an assistant professor of medicine at Weill Cornell Medicine has been awarded a $4 million, seven-year MERIT grant from the National Cancer Institute (NCI) at the National Institutes of Health (NIH).

The “Method for Extending Research In Time” (...

Researchers from Weill Cornell Medicine provide the first national estimate of caregivers’ pain and arthritis experiences that can limit their ability to perform necessary tasks while caring for older family members. The study suggests screening caregivers for pain issues and offering interventions, particularly to populations that are traditionally underserved. This may help avoid higher health costs and improve the quality of life for both caregivers and their care recipients.

This...

A team led by researchers at Weill Cornell Medicine has used an AI-based approach to uncover underlying patterns among the conditions in which people are born, grow, live, work, and age, termed social determinants of health (SDoH), and then linked each pattern to children’s health outcomes. Compared with traditional approaches, the strategy, in principle, provides a more objective and comprehensive picture of potential social factors that affect child health, which in turn, can enable better...

Cathy Garzio, a distinguished academic medicine administrator, has been appointed executive vice provost and chief operating officer of Weill Cornell Medicine, effective early February.

In her new role at Weill Cornell Medicine, Garzio will oversee a portfolio of administrative departments including Human Resources, Facilities Management, Capital Planning and Construction, and Student and Faculty Housing, which collectively provide efficient daily operations for the institution’s...

Researchers at Weill Cornell Medicine found that partnering with local religious leaders boosted adoption of family planning methods in Tanzania. The findings present a novel strategy for increasing global awareness and use of contraception in regions where faith leaders are trusted messengers in the community.

The study, published in The Lancet Global Health on Nov. 14, showed that...

A team at Weill Cornell Medicine has mapped the location and spatial features of blood-forming cells within human bone marrow. Their findings confirm hypotheses about the anatomy of this tissue and provide a powerful new means to study diseases, ranging from noncancerous conditions, such as sickle cell anemia, to malignant conditions, such as acute leukemia, that affect bone marrow.  

For the...

In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, which has been the standard treatment, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Angioplasty involves the widening of a narrowed artery with a small, balloon-like mechanism. A resorbable scaffold is a stent-like structure that props the artery open...

New York, NY (November 9, 2023) - The Allen Discovery Center (ADC) for Neuroimmune Interactions at the Icahn School of Medicine at Mount Sinai hopes to revolutionize the field of medicine with a groundbreaking project to understand how the human body senses health and disease.

Spearheaded by Dr. Brian S. Kim of Mount Sinai and co-led by Dr. David...

A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in type 2 diabetes, according to a new study by Weill Cornell Medicine investigators. The preclinical discovery, reported Nov. 9 in Nature Chemical Biology, provides a new chemical tool for probing the biology of diabetes, and...

Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with type 2 diabetes—a condition that affects more than half a billion people worldwide.

This study, published in the Journal of Clinical Investigation on Sept. 15...

Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain triggering a reaction that damages blood vessels and leads to neurodegeneration.

The findings, published in Molecular Neurodegeneration on Oct. 3, may help researchers understand how dementia develops...

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial showed that the “radiopharmaceutical” was well tolerated and demonstrated promising antitumor activity, according to a new study published on Nov. 3 in the Journal of Clinical Oncology.

The...

A surprising mechanism that makes some cancers treatment-resistant has been discovered by Weill Cornell Medicine and NewYork-Presbyterian investigators.  The mechanism, which involves the shuttling of messenger RNAs (mRNAs) from the nucleus to the cytoplasm, ultimately facilitates DNA repair in cancer cells. These cancer cells can thereby thwart treatments aimed at damaging their DNA.

In a project encompassing both fundamental research and...

Weill Cornell Medicine is expanding its real estate agreement at 575 Lexington Ave. to provide state-of-the-art clinical care at the Midtown Manhattan location by 2025.

The new space, which represents a 100,000-foot expansion of current space in the same building, will be renovated to support exceptional patient services in a well-situated midtown location with convenient access from Grand Central Terminal and three major subway lines.

“This expansion project is very exciting for...

Ambulance-based mobile stroke units (MSU) can reach patients faster to deliver clost-busting drugs that increase the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, according to researchers at Weill Cornell Medicine, NewYork-Presbyterian, UTHealth Houston, Memorial Hermann-Texas Medical Center and five other medical centers across the United States.

The study,...